• 106 Citations
  • 6 h-Index
20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2008-2013 Ph.D., Department of Pharmacy, National Taiwan University
  • 1996-1998 M.S., Department of Pharmacy, National Taiwan University
  • 1992-1996 B.S., School of Pharmacy, Kaohsiung Medical University

Experience

  • Researcher, Department of Medical Research, Taipei Medical University Hospital 
  • 2018.08- Assistant Professor, Department of Pharmacology, College of Medicine, Taipei Medical University 
  • 2013.02-2017.07 Postdoctoral Research Fellow, Department and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University
  • 1999.09-2008.08 Pharmacist, National Taiwan University Hospital
  • 1998.09-1999.08 Pharmacist, Linkou Chang Gung Memorial Hospital

Fingerprint Dive into the research topics where Shiu-Wen Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 106 Citations
  • 6 h-Index
  • 15 Article

Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade

Huang, S. W., Chyuan, I. T., Shiue, C., Yu, M. C., Hsu, Y. F. & Hsu, M. J., Jan 1 2020, In : Journal of Cellular and Molecular Medicine. 24, 2, p. 1822-1836 15 p.

Research output: Contribution to journalArticle

Open Access
  • 3 Citations (Scopus)

    A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling

    Lien, J. C., Chung, C. L., Huang, T. F., Chang, T. C., Chen, K. C., Gao, G. Y., Hsu, M. J. & Huang, S. W., Oct 1 2019, In : British Journal of Pharmacology. 176, 20, p. 4034-4049 16 p.

    Research output: Contribution to journalArticle

  • WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade

    Huang, S. W., Yang, H. Y., Huang, W. J., Chen, W. C., Yu, M. C., Wang, S. W., Hsu, Y. F. & Hsu, M. J., Nov 6 2019, In : Frontiers in Oncology. 9, 1188.

    Research output: Contribution to journalArticle

    Open Access
  • A novel hydroxamate-based compound WMJ-J-09 causes head and neck squamous cell carcinoma cell death via LKB1-AMPK-p38MAPK-p63-survivin cascade

    Yen, C. S., Choy, C. S., Huang, W. J., Huang, S. W., Lai, P. Y., Yu, M. C., Shiue, C., Hsu, Y. F. & Hsu, M. J., Mar 1 2018, In : Frontiers in Pharmacology. 9, MAR, p. 1-17 17 p., 167.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Inhibitory Effects of an Orally Active Thromboxane A2 Receptor Antagonist, nstpbp5185, on Atherosclerosis in ApoE-Deficient Mice

    Huang, S. W., Lien, J. C., Kuo, S. C. & Huang, T. F., Jan 1 2018, In : Thrombosis and Haemostasis. 118, 2, p. 401-414 14 p.

    Research output: Contribution to journalArticle

  • 3 Citations (Scopus)